Jefferies Financial Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-25,000
Closed -$1.57M 1745
2026
Q1
$1.57M Buy
+25,000
New +$1.74M 0.01% 733
2024
Q4
Sell
-25,000
Closed -$1.68M 1655
2024
Q3
$1.68M Hold
25,000
0.01% 645
2024
Q2
$2.83M Hold
25,000
0.03% 444
2024
Q1
$3.47M Sell
25,000
-15,000
-38% -$1.89M 0.03% 405
2023
Q4
$4.96M Buy
+40,000
New +$4.09M 0.03% 409
2023
Q3
Sell
-1,100
Closed -$141K 1695
2023
Q2
$141K Sell
1,100
-38,100
-97% -$4.61M ﹤0.01% 1480
2023
Q1
$4.55M Buy
+39,200
New +$4.39M 0.04% 394

Other funds holding DXCM

Jefferies Financial Group's DXCM Position: Q2 2026 in Review

Jefferies Financial Group increased its DexCom (DXCM) stake by 199% in Q2 2026, buying an estimated $2.72M and bringing the position to 61,434 shares worth $4.14M. The position accounts for 0.03% of the portfolio, ranked #433.

Jefferies Financial Group first reported a position in DXCM in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.97M in Q4 2022. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Jefferies Financial Group held 61,434 shares of DexCom worth $4.14M as of Q2 2026.
  • Jefferies Financial Group bought 40,879 DexCom shares in Q2 2026, an estimated $2.72M.
  • DexCom made up 0.03% of Jefferies Financial Group's portfolio in Q2 2026, its #433 holding.
  • Jefferies Financial Group first reported a position in DexCom in Q4 2022 and has held it in 15 quarters since.
  • Jefferies Financial Group's DexCom position peaked at $7.97M in Q4 2022.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.